Immune cells from your own tumor could fight stomach and bowel cancers
NCT ID NCT04960072
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This early-phase study tests a personalized cell therapy for people with advanced gastrointestinal tumors that have not responded to standard treatments. Doctors take immune cells from the patient's own tumor, grow them in a lab, and infuse them back after a short chemotherapy preparation. The goal is to see if this approach can shrink tumors and improve survival, while monitoring side effects closely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Tenth People's Hospital
RECRUITINGShanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New antibody drug targets Hard-to-Treat cancers
- New drug aims to stop Chemo-Induced bleeding risk in stomach and colon cancers
- New stem cell transplant shows promise for kids with tough cancers
- New drug BL-B01D1 shows promise for Hard-to-Treat cancers
- Experimental drug BL-M02D1 takes first steps against tough cancers
- New drug candidate BL-M02D1 enters human trials for Hard-to-Treat cancers